Dr. Huntington Potter, CU Anschutz Medical Campus professor and director of the Rocky Mountain Alzheimer’s Disease Center, speaks with CU’s Ken McConnellogue about:

- The drug leukine, which shows encouraging results
- Why Down syndrome research is important in Alzheimer’s research
- What the center is looking for in clinical studies